These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29557239)

  • 1. Role of quantitative analysis of T2 relaxation time in differentiating benign from malignant breast lesions.
    Liu L; Yin B; Shek K; Geng D; Lu Y; Wen J; Kuai X; Peng W
    J Int Med Res; 2018 May; 46(5):1928-1935. PubMed ID: 29557239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Findings in Papillary Breast Lesions: An Analysis of Ductal Findings on Magnetic Resonance Imaging and Ultrasound.
    Sarica O; Dokdok M
    J Comput Assist Tomogr; 2018; 42(4):542-551. PubMed ID: 29613991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI.
    Kim BS
    Ann Nucl Med; 2012 Feb; 26(2):131-7. PubMed ID: 22006539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of BI-RADS ultrasonic scores of direct and indirect ultrasonographic signs in diagnosis of solid breast lesions].
    Gao JX; Yu XQ; Yao LH
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):465-9. PubMed ID: 21875490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI.
    Meng T; He N; He H; Liu K; Ke L; Liu H; Zhong L; Huang C; Yang A; Zhou C; Qian L; Xie C
    Cancer Imaging; 2020 Dec; 20(1):88. PubMed ID: 33317609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differential diagnosis of benign and malignant breast lesions using quantitative synthetic magnetic resonance imaging].
    Zhang L; Zhao X; Yin X
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):457-462. PubMed ID: 35527481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.
    Zhang B; Zhu B; Li M; Yuan L; Yuan L; Zhang X; Yu H; Li C; Lu F; Zhou Z; Zhuang X
    Acta Radiol; 2012 Jul; 53(6):607-14. PubMed ID: 22761342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficient in differentiation between malignant and benign breast masses: does size matter?
    Wan CW; Lee CY; Lui CY; Fong CY; Lau KC
    Clin Radiol; 2016 Feb; 71(2):170-7. PubMed ID: 26688549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging.
    Du J; Wang L; Wan CF; Hua J; Fang H; Chen J; Li FH
    Eur J Radiol; 2012 Dec; 81(12):3890-9. PubMed ID: 23062280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MR tomographic characterization of suspicious breast lesions with dynamic susceptibility-weighted T2* sequences].
    Dannert S; Krück W; Schick F; Claussen CD; Müller-Schimpfle M
    Rofo; 2001 Jan; 173(1):38-43. PubMed ID: 11225415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can breast MRI computer-aided detection (CAD) improve radiologist accuracy for lesions detected at MRI screening and recommended for biopsy in a high-risk population?
    Arazi-Kleinman T; Causer PA; Jong RA; Hill K; Warner E
    Clin Radiol; 2009 Dec; 64(12):1166-74. PubMed ID: 19913125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second reading of breast imaging at the hospital department of radiology: reasonable or waste of money?].
    Teifke A; Vomweg TW; Hlawatsch A; Nasresfahani A; Kern A; Victor A; Schmidt M; Bittinger F; Düber C
    Rofo; 2006 Mar; 178(3):330-6. PubMed ID: 16508842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging.
    Jacobs MA; Barker PB; Bluemke DA; Maranto C; Arnold C; Herskovits EH; Bhujwalla Z
    Radiology; 2003 Oct; 229(1):225-32. PubMed ID: 14519877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
    Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
    Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of (99m)Tc-3PRGD2 scintimammography for differentiation of malignant from benign breast lesions: Comparison of visual and semi-quantitative analysis.
    Chen Q; Xie Q; Zhao M; Chen B; Gao S; Zhang H; Xing H; Ma Q
    Hell J Nucl Med; 2015; 18(3):193-8. PubMed ID: 26574690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of T2 mapping in quantifying and discriminating uterine lesions under different magnetic field strengths: 1.5 T vs. 3.0 T.
    Zhu L; Lu W; Wang F; Wang Y; Wu PY; Zhou J; Liu H
    BMC Med Imaging; 2023 Jan; 23(1):1. PubMed ID: 36600192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.